Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

Author： Schmidt J. Elflein K. Stienekemeier M. Rodriguez-Palmero M. Schneider C. Toyka K.V. Gold R. Hunig T.

Publisher： Elsevier

ISSN： 0165-5728

Source： Journal of Neuroimmunology, Vol.140, Iss.1, 2003-07, pp. : 143-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of experimental autoimmune diabetes in mice by treatment with leflunomide

By Stosic-Grujicic S. Dimitrijevic M. Bartlett R.R.

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4132-4133

Elsevier

Access to resources Recommend Favorite

Experimental Autoimmune Meningitis: A Novel Neurological Disease in CD28-Deficient Mice

By Perrin P.J. Lavi E. Rumbley C.A. Zekavat S.A. Phillips S.M.

Clinical Immunology, Vol. 91, Iss. 1, 1999-04 ,pp. : 41-49

Academic Press

Access to resources Recommend Favorite

Anti-CD137 antibodies in the treatment of autoimmune disease and cancer

By Mittler Robert Foell Juergen McCausland Megan Strahotin Simona Niu Liguo Bapat Abhijit Hewes L.

Immunologic Research, Vol. 29, Iss. 1-3, 2004-06 ,pp. : 197-208

Humana Press, Inc

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Leukemia

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 663-675

Bentham Science Publishers

Access to resources Recommend Favorite

Development of monoclonal antibodies specific for Ricinus agglutinins

By Brandon David Hernlem Bradley

Food and Agricultural Immunology, Vol. 20, Iss. 1, 2009-03 ,pp. : 11-22

Taylor & Francis Ltd

Access to resources Recommend Favorite